M. Dib

557 total citations
7 papers, 47 citations indexed

About

M. Dib is a scholar working on Neurology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, M. Dib has authored 7 papers receiving a total of 47 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Neurology, 2 papers in Cellular and Molecular Neuroscience and 2 papers in Oncology. Recurrent topics in M. Dib's work include Peripheral Neuropathies and Disorders (3 papers), Hereditary Neurological Disorders (2 papers) and Peer-to-Peer Network Technologies (1 paper). M. Dib is often cited by papers focused on Peripheral Neuropathies and Disorders (3 papers), Hereditary Neurological Disorders (2 papers) and Peer-to-Peer Network Technologies (1 paper). M. Dib collaborates with scholars based in France, Brazil and Germany. M. Dib's co-authors include C Vital, A. Vital, Brigitte Pegourié, Gaëlle Guillerm, Chantal Doyen, C. Hulin, C Brechenmacher, Philippe Rodon, J.-M. Virion and Philippe Moreau and has published in prestigious journals such as Journal of Clinical Oncology, Acta Neuropathologica and Journal of the Neurological Sciences.

In The Last Decade

M. Dib

6 papers receiving 45 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Dib France	5	20	20	15	13	11	7	47
Payam Soltanzadeh United States	5	28 1.4×	6 0.3×	28 1.9×	21 1.6×	19 1.7×	12	96
Luisa Grazian Italy	4	16 0.8×	9 0.5×	10 0.7×	7 0.5×	6 0.5×	5	71
A.F. Serre France	3	34 1.7×	14 0.7×	5 0.3×	7 0.5×	3 0.3×	3	48
Tsuneyoshi Seki Japan	5	22 1.1×	4 0.2×	39 2.6×	9 0.7×	4 0.4×	5	91
Pietro Perini Italy	4	9 0.5×	24 1.2×	15 1.0×	2 0.2×	9 0.8×	5	42
Carolin Geitner Germany	4	24 1.2×	3 0.1×	17 1.1×	21 1.6×	33 3.0×	6	69
Mickey Huang United States	6	13 0.7×	4 0.2×	43 2.9×	6 0.5×	11 1.0×	7	111
Junjun Lu United States	5	2 0.1×	17 0.8×	20 1.3×	8 0.6×	13 1.2×	10	55
Ivan Karin Germany	5	9 0.5×	9 0.5×	36 2.4×	19 1.5×		14	94
John Trusheim United States	3	8 0.4×	3 0.1×	12 0.8×	5 0.4×	8 0.7×	7	53

Countries citing papers authored by M. Dib

Since Specialization

Citations

This map shows the geographic impact of M. Dib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Dib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Dib more than expected).

Fields of papers citing papers by M. Dib

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Dib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Dib. The network helps show where M. Dib may publish in the future.

Co-authorship network of co-authors of M. Dib

This figure shows the co-authorship network connecting the top 25 collaborators of M. Dib. A scholar is included among the top collaborators of M. Dib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Dib. M. Dib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Casuscelli, Jozefina, Thomas Büttner, Christopher Darr, et al.. (2025). Enfortumab vedotin plus pembrolizumab in metastatic urothelial carcinoma: First results on outcomes and safety in a German multicenter real-world patient cohort (GUARDIANS).. Journal of Clinical Oncology. 43(5_suppl). 715–715.

2.

Jaccard, Arnaud, Lionel Karlin, Sylvain Choquet, et al.. (2015). A Prospective Phase II Trial of Lenalidomide and Dexamethasone (Len-Dex) in POEMS Syndrome. Clinical Lymphoma Myeloma & Leukemia. 15. e57–e57. 6 indexed citations

3.

Hulin, C., J.-M. Virion, Xavier Leleu, et al.. (2007). Comparison of melphalan-prednisone-thalidomide (MP-T) to melphalan-prednisone (MP) in patients 75 years of age or older with untreated multiple myeloma (MM). Preliminary results of the randomized, double-blind, placebo controlled IFM 01–01 trial. Journal of Clinical Oncology. 25(18_suppl). 8001–8001. 15 indexed citations

4.

Hunault, Mathilde, Aline Schmidt, Vincent Lévy, et al.. (2005). rHuEpo before high-dose therapy allows autologous peripheral stem-cell transplantation without red blood cell transfusion: a pilot study. Bone Marrow Transplantation. 35(9). 903–907. 4 indexed citations

5.

Weigang, Li, et al.. (2002). <title>Using ant-behavior-based simulation model AntWeb to improve website organization</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 4730. 229–240. 3 indexed citations

6.

Dib, M., et al.. (1987). The C57BL mice: An animal model for inflammatory demyelinating polyneuropathy. Journal of the Neurological Sciences. 81(1). 101–111. 6 indexed citations

7.

Vital, C, et al.. (1986). Relapsing inflammatory demyelinating polyneuropathy in a diabetic patient. Acta Neuropathologica. 71(1-2). 94–99. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact